Search

The article offers information on the Massachusetts Eye and Ear Infirmary (MEEI) in Boston, Massachusetts and its goal of developing residents into first-class clinicians and well-rounded academicians. According to MEEI residency program director John I. Loewenstein, MD, residents need to publish one research paper during their residency. Joan W. Miller, MD, chief of ophthalmology at MEEI, describes the culture at MEEI as one that is dedicated to teaching residents.

The article focuses on the life and works of M. Judah Folkman, founder of the vascular biology program at Children's Hospital Boston, Massachusetts, who died on January 14, 2008 due to a heart attack. Folkman was born in 1933 in Cleveland, Ohio, and studied at Harvard Medical School, Boston, Massachusetts. It is stated that his work in cancer research led to breakthroughs in treating age-related macular degeneration (AMD). Comments of Folkman's colleagues regarding him have been given.

Announces the 26th annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) and the 14th annual meeting of the American Society of Ophthalmic Administrators (ASOA) to be held from May 20 to 24, 2000 in Boston, Massachusetts. Hall of Fame Awards; Scientific paper presentations; Course offerings.

The article reports on a meeting on glaucoma diagnosis and treatment held recently in Boston, Massachusetts. The meeting highlights that the National Library of Medicine's EntrezPubMed search engine is a useful tool for quickly finding published study results and other information from the medical literature. Understanding how to evaluate this information and apply it to patient treatment is the key to practicing evidence-based medicine. It also suggests that the Early Manifest Glaucoma Trial demonstrated that glaucoma treatment lowers progression by 50 percent in representative early-to-moderate open-angle glaucoma.

The article reports on the results of a study by researchers at Massachusetts Eye and Ear Infirmary in Boston, which showed that inflammation plays a role in the pathogenesis of wet age-related macular degeneration (AMD). The researchers have discovered the pathogen capable of inducing chronic infection, Chlamydia pneumoniae, in the diseased eye tissue of several patients with wet AMD.